| UniProt ID | STK33_HUMAN | |
|---|---|---|
| UniProt AC | Q9BYT3 | |
| Protein Name | Serine/threonine-protein kinase 33 | |
| Gene Name | STK33 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 514 | |
| Subcellular Localization | Cytoplasm, perinuclear region. | |
| Protein Description | Serine/threonine protein kinase which phosphorylates VIME. May play a specific role in the dynamic behavior of the intermediate filament cytoskeleton by phosphorylation of VIME (By similarity). Not essential for the survival of KRAS-dependent AML cell lines.. | |
| Protein Sequence | MADSGLDKKSTKCPDCSSASQKDVLCVCSSKTRVPPVLVVEMSQTSSIGSAESLISLERKKEKNINRDITSRKDLPSRTSNVERKASQQQWGRGNFTEGKVPHIRIENGAAIEEIYTFGRILGKGSFGIVIEATDKETETKWAIKKVNKEKAGSSAVKLLEREVNILKSVKHEHIIHLEQVFETPKKMYLVMELCEDGELKEILDRKGHFSENETRWIIQSLASAIAYLHNNDIVHRDLKLENIMVKSSLIDDNNEINLNIKVTDFGLAVKKQSRSEAMLQATCGTPIYMAPEVISAHDYSQQCDIWSIGVVMYMLLRGEPPFLASSEEKLFELIRKGELHFENAVWNSISDCAKSVLKQLMKVDPAHRITAKELLDNQWLTGNKLSSVRPTNVLEMMKEWKNNPESVEENTTEEKNKPSTEEKLKSYQPWGNVPDANYTSDEEEEKQSTAYEKQFPATSKDNFDMCSSSFTSSKLLPAEIKGEMEKTPVTPSQGTATKYPAKSGALSRTKKKL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Phosphorylation | DSGLDKKSTKCPDCS CCCCCCCCCCCCCCC | 38.55 | 26670566 | |
| 11 | Phosphorylation | SGLDKKSTKCPDCSS CCCCCCCCCCCCCCC | 45.61 | 26670566 | |
| 20 | Phosphorylation | CPDCSSASQKDVLCV CCCCCCCCCCCEEEE | 39.45 | 28961369 | |
| 29 | Phosphorylation | KDVLCVCSSKTRVPP CCEEEEECCCCCCCC | 17.93 | 30622161 | |
| 30 | Phosphorylation | DVLCVCSSKTRVPPV CEEEEECCCCCCCCE | 32.68 | 30622161 | |
| 31 | Ubiquitination | VLCVCSSKTRVPPVL EEEEECCCCCCCCEE | 24.85 | - | |
| 43 | Phosphorylation | PVLVVEMSQTSSIGS CEEEEECCCCCCCCC | 19.46 | 27732954 | |
| 45 | Phosphorylation | LVVEMSQTSSIGSAE EEEECCCCCCCCCHH | 19.69 | 27732954 | |
| 46 | Phosphorylation | VVEMSQTSSIGSAES EEECCCCCCCCCHHH | 16.60 | 27732954 | |
| 47 | Phosphorylation | VEMSQTSSIGSAESL EECCCCCCCCCHHHH | 34.06 | 27732954 | |
| 50 | Phosphorylation | SQTSSIGSAESLISL CCCCCCCCHHHHHHH | 27.48 | 22199227 | |
| 53 | Phosphorylation | SSIGSAESLISLERK CCCCCHHHHHHHHHH | 30.62 | 27732954 | |
| 56 | Phosphorylation | GSAESLISLERKKEK CCHHHHHHHHHHHHH | 29.48 | 29523821 | |
| 73 | Acetylation | NRDITSRKDLPSRTS CCCCCCCCCCCCCCC | 64.48 | 7825429 | |
| 79 | Phosphorylation | RKDLPSRTSNVERKA CCCCCCCCCCHHHHH | 29.05 | 28555341 | |
| 85 | Ubiquitination | RTSNVERKASQQQWG CCCCHHHHHHHHHHC | 38.59 | - | |
| 87 | Phosphorylation | SNVERKASQQQWGRG CCHHHHHHHHHHCCC | 31.40 | - | |
| 100 | Ubiquitination | RGNFTEGKVPHIRIE CCCCCCCCCCEEEEE | 46.49 | - | |
| 116 | Phosphorylation | GAAIEEIYTFGRILG CCCEEEEEEHHHHHC | 10.17 | - | |
| 141 | Ubiquitination | TDKETETKWAIKKVN CCCHHHHHHHHHHHC | 28.53 | - | |
| 154 | Phosphorylation | VNKEKAGSSAVKLLE HCHHHCCHHHHHHHH | 21.71 | 21406692 | |
| 155 | Phosphorylation | NKEKAGSSAVKLLER CHHHCCHHHHHHHHH | 35.84 | 21406692 | |
| 158 | Ubiquitination | KAGSSAVKLLEREVN HCCHHHHHHHHHHHH | 47.25 | - | |
| 168 | Ubiquitination | EREVNILKSVKHEHI HHHHHHHHHCCHHCE | 49.78 | - | |
| 240 | Ubiquitination | DIVHRDLKLENIMVK CCCCCCCCHHCEEEE | 59.03 | - | |
| 271 | Ubiquitination | TDFGLAVKKQSRSEA EECCEEEECCCCCHH | 39.22 | - | |
| 301 | Phosphorylation | VISAHDYSQQCDIWS HHCCCCCHHHCCHHH | 21.60 | 27251275 | |
| 356 | Phosphorylation | SISDCAKSVLKQLMK HHHHHHHHHHHHHHC | 17.73 | 21406692 | |
| 359 | Ubiquitination | DCAKSVLKQLMKVDP HHHHHHHHHHHCCCH | 38.95 | - | |
| 373 | Ubiquitination | PAHRITAKELLDNQW HHHCCCHHHHHHCCC | 40.00 | - | |
| 382 | Phosphorylation | LLDNQWLTGNKLSSV HHHCCCCCCCCCCCC | 35.43 | - | |
| 385 | Acetylation | NQWLTGNKLSSVRPT CCCCCCCCCCCCCCC | 51.60 | 25953088 | |
| 385 | Ubiquitination | NQWLTGNKLSSVRPT CCCCCCCCCCCCCCC | 51.60 | - | |
| 387 | Phosphorylation | WLTGNKLSSVRPTNV CCCCCCCCCCCCCCH | 28.53 | 24719451 | |
| 388 | Phosphorylation | LTGNKLSSVRPTNVL CCCCCCCCCCCCCHH | 32.36 | 28796482 | |
| 392 | Phosphorylation | KLSSVRPTNVLEMMK CCCCCCCCCHHHHHH | 27.65 | 28796482 | |
| 402 | Ubiquitination | LEMMKEWKNNPESVE HHHHHHHHCCHHHHH | 48.19 | - | |
| 407 | Phosphorylation | EWKNNPESVEENTTE HHHCCHHHHHHCCCC | 35.77 | - | |
| 420 | Phosphorylation | TEEKNKPSTEEKLKS CCCCCCCCHHHHHHH | 50.49 | - | |
| 421 | Phosphorylation | EEKNKPSTEEKLKSY CCCCCCCHHHHHHHC | 57.60 | - | |
| 427 | Phosphorylation | STEEKLKSYQPWGNV CHHHHHHHCCCCCCC | 39.16 | 26074081 | |
| 428 | Phosphorylation | TEEKLKSYQPWGNVP HHHHHHHCCCCCCCC | 19.60 | 26074081 | |
| 439 | Phosphorylation | GNVPDANYTSDEEEE CCCCCCCCCCHHHHH | 14.89 | 30576142 | |
| 440 | Phosphorylation | NVPDANYTSDEEEEK CCCCCCCCCHHHHHH | 29.52 | 22617229 | |
| 441 | Phosphorylation | VPDANYTSDEEEEKQ CCCCCCCCHHHHHHH | 32.44 | 22617229 | |
| 449 | Phosphorylation | DEEEEKQSTAYEKQF HHHHHHHCHHHHHHC | 26.52 | 26852163 | |
| 450 | Phosphorylation | EEEEKQSTAYEKQFP HHHHHHCHHHHHHCC | 30.66 | 26852163 | |
| 452 | Phosphorylation | EEKQSTAYEKQFPAT HHHHCHHHHHHCCCC | 24.61 | 26852163 | |
| 454 | Ubiquitination | KQSTAYEKQFPATSK HHCHHHHHHCCCCCC | 44.56 | - | |
| 468 | Phosphorylation | KDNFDMCSSSFTSSK CCCCCCCCCCCCCCC | 23.52 | 18691976 | |
| 469 | Phosphorylation | DNFDMCSSSFTSSKL CCCCCCCCCCCCCCC | 25.25 | 21712546 | |
| 470 | Phosphorylation | NFDMCSSSFTSSKLL CCCCCCCCCCCCCCC | 19.09 | 21712546 | |
| 472 | Phosphorylation | DMCSSSFTSSKLLPA CCCCCCCCCCCCCCC | 33.76 | 29116813 | |
| 473 | Phosphorylation | MCSSSFTSSKLLPAE CCCCCCCCCCCCCCC | 24.38 | 29514088 | |
| 474 | Phosphorylation | CSSSFTSSKLLPAEI CCCCCCCCCCCCCCC | 25.02 | 29514088 | |
| 488 | Phosphorylation | IKGEMEKTPVTPSQG CCCEEEECCCCCCCC | 15.08 | 24505115 | |
| 491 | Phosphorylation | EMEKTPVTPSQGTAT EEEECCCCCCCCCCC | 20.58 | 21815630 | |
| 493 | Phosphorylation | EKTPVTPSQGTATKY EECCCCCCCCCCCCC | 31.69 | 22817900 | |
| 496 | Phosphorylation | PVTPSQGTATKYPAK CCCCCCCCCCCCCCC | 24.42 | 22817900 | |
| 498 | Phosphorylation | TPSQGTATKYPAKSG CCCCCCCCCCCCCCC | 30.83 | 24505115 | |
| 500 | Phosphorylation | SQGTATKYPAKSGAL CCCCCCCCCCCCCCC | 12.22 | - | |
| 504 | Phosphorylation | ATKYPAKSGALSRTK CCCCCCCCCCCCCCC | 31.25 | - | |
| 508 | Phosphorylation | PAKSGALSRTKKKL- CCCCCCCCCCCCCC- | 37.05 | 24505115 | |
| 510 | Phosphorylation | KSGALSRTKKKL--- CCCCCCCCCCCC--- | 43.79 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 382 | T | Phosphorylation | Kinase | STK33 | Q9BYT3 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of STK33_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STK33_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HS90B_HUMAN | HSP90AB1 | physical | 22451720 | |
| HS90A_HUMAN | HSP90AA1 | physical | 22451720 | |
| CDC37_HUMAN | CDC37 | physical | 22451720 | |
| HERC2_HUMAN | HERC2 | physical | 22451720 | |
| BAG2_HUMAN | BAG2 | physical | 22451720 | |
| UBP5_HUMAN | USP5 | physical | 22451720 | |
| UBP15_HUMAN | USP15 | physical | 22451720 | |
| A4_HUMAN | APP | physical | 21832049 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441 AND THR-491, ANDMASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-469 AND SER-470, ANDMASS SPECTROMETRY. | |